Capital Analysts, LLC
- SEC CIK
- 0001624758
- Latest filing
- Aug 5, 2026
VIR holding history
Vir Biotechnology, Inc. in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VIR overviewAll 13F holders of VIRFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −320−100.0% | Sold out | Holders |
| Q2 2024 | 320 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 320 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 320 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 320 | $3.00K | <0.1% | −15−4.5% | Reduced | Holders |
| Q2 2023 | 335 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 335 | $8.00K | <0.1% | +90+36.7% | Added | Holders |
| Q4 2022 | 245 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 245 | $5.00K | <0.1% | +50+25.6% | Added | Holders |
| Q2 2022 | 195 | $5.00K | <0.1% | +195 | New | Holders |